Two studies were conducted to compare nitrogen (N) and glutamate metabolism in Polypay and percentage White Dorper lambs.First, a two-phase digestion/N metabolism trial was conducted with 18 wether lambs of three genetic types: Polypay (PP), 1/2 White Dorper 1/2 Polypay (1/2 D), and 3/4 White Dorper 1/4 Polypay (3/4 D). Six lambs of each genetic type were fed a high roughage diet (HR; Phase 1) or high concentrate diet (HC; Phase 2). DM and N digestion was higher for 1/2 D than PP or 3/4 D fed HC. N retention was highest for 1/2 D regardless of diet.The second study analyzed the effect of genetic type on glutamate transporter and metabolizing enzyme expression in liver, kidney, longissimus dorsi muscle (LD muscle), and subcutaneous fat (Sub Q Fat) tissue of 18 wether lambs of three genetic types: PP, 1/2 D, and 15 /16 White Dorper 1/16 Polypay (15 /16 D). Tissue samples were analyzed for protein and mRNA content of GS, GDH, ALT, EAAC1, and GLT-1. Glutamate transport and metabolism capacity was lowest for the heavier muscled 15 /16 D lambs.The results suggest genetic type has an effect on N metabolism due to differential expression of glutamate transporters and metabolizing enzymes.

O desenvolvimento humano pode ser influenciado pelo ambiente. Estímulos recebidos ao longo da vida determinam seu progresso e sucesso. Estímulos positivos levam ao desenvolvimento de habilidades, melhorando funções cognitivas e da memória, enquanto estímulos negativos podem predispor a patologias como o estresse. Eventos estressantes durante a infância aumentam a predisposição para o desenvolvimento de transtornos psiquiátricos ao longo da vida. A separação materna, modelo animal de estresse pós-natal, promove diversas alterações comportamentais e encefálicas. Animais submetidos à separação materna apresentam comportamentos que mimetizam doenças psiquiátricas humanas. Por outro lado, diversos trabalhos sugerem que o enriquecimento ambiental pode ter efeito benéfico na reversão ou atenuação de modificações comportamentais e encefálicas promovidas por modelos animais de depressão, esquizofrenia, ansiedade e hiperatividade. Esses aspectos motivaram-nos a estudar se as alterações causadas por estresse podem ser revertidas ou atenuadas pelo enriquecimento do ambiente. Há evidências que sugerem um importante envolvimento de células gliais e de transportadores de glutamato presentes nessas células em modelos animais de transtornos psiquiátricos. Sendo assim, investigamos a expressão de mRNA e proteínas de dois transportadores de glutamato gliais e um neuronal, do receptor de glutamato AMPA, de marcadores gliais GFAP, S100?, glutamina sintase (GS) e do marcador de neurônios maduros NeuN na camada molecular e granular do giro denteado do hipocampo de ratos de 60 dias. Observamos que a separação materna diminui a expressão das proteínas GLAST, GLT-1, GS e NeuN, reduz a expressão dos genes Gria1 (AMPA) e S100?, e aumenta a expressão da proteína EAAC1 no giro denteado. Nossos dados sugerem uma reversão das alterações causadas pela separação materna em relação ao gene Gria1/AMPA e às proteínas GLAST, GLT-1 e EAAC1 após o enriquecimento ambiental. Portanto, o enriquecimento ambiental pode reverter as modificações causadas pela separação materna nas vias glutamatérgicas. Esses efeitos benéficos podem ser investigados para auxiliar no tratamento de transtornos psiquiátricos relacionados à separação materna. / Human development can be influenced by the environment. Stimuli received throughout life determine its progress and success. Positive stimuli lead to development of skills, improving cognitive and memory functions, while negative stimuli may predispose to pathologies such as stress. Stressful events during childhood increase the predisposition to psychiatric disorders throughout life. Maternal separation, an animal model of postnatal stress, promotes several behavioral and encephalic changes. Animals submitted to maternal separation stage behaviors associated with psychiatric diseases in humans. On the other hand, some researches have suggested that environmental enrichment may have some beneficial effects on the reversal or attenuation of behavioral and encephalic modifications promoted by animal models of depression, schizophrenia, anxiety and hyperactivity, which motivates us to study if these changes, stirred by this kind of stress, can be reversed or mitigated by environmental enrichment. There are evidences suggesting the involvement of glial cells and glutamate transporters existent in these cells in psychiatric disorders and animal models of these disorders. Therefore, we investigated mRNA and protein expression of two glial and one neuronal glutamate transporters, AMPA glutamate receptor, glial markers GFAP, S100?, glutamine synthase (GS), and the NeuN neuronal marker in the molecular and granular layer of the hippocampal gyrus in sixty-days-old rats. We observed that maternal separation decreases expression of GLAST, GLT-1, GS and NeuN proteins, reduces Gria1 (AMPA) and S100? gene expression, and increases EAAC1 protein expression in the dentate gyrus. After environmental enrichment, our data suggests a reversal of the maternal separation changes in the Gria1/AMPA gene and the GLAST, GLT-1 and EAAC1 proteins. Therefore, environmental enrichment may reverse the maternal separation changes in the glutamatergic pathways. These beneficial effects may be investigated to aid in the treatment of psychiatric disorders related to maternal separation.

The retinogeniculate synapse, the connection between retinal ganglion cells (RGCs) and thalamic relay neurons, undergoes extensive remodeling and refinement in the first few postnatal weeks. While many studies have focused on this process, little is known about the factors that influence excitatory transmission during this dynamic period. A major goal of my dissertation research was to identify mechanisms that regulate glutamate release and clearance at the developing synapse. First, we investigated the role of glutamate transporters and metabotropic glutamate receptors (mGluRs) in shaping excitatory transmission. Early in development, we found presynaptic group II/III mGluRs are present and are activated by glutamate released from RGCs following optic tract stimulation at natural frequencies. This response was found to diminish with age, but glutamate transporters continued to shape synaptic currents throughout development. The finding that glutamate is able to escape the synaptic cleft and bind extrasynaptic high-affinity mGluRs led us to speculate that glutamate might also diffuse to neighboring synapses and bind ionotropic glutamate receptors opposing quiescent release sites. Excitatory currents recorded from immature, but not mature, retinogeniculate synapses display a prolonged decay timecourse. We found evidence that both asynchronous release of glutamate as well as spillover of glutamate between neighboring synapses contributes to these slowly decaying synaptic currents. Furthermore, we uncovered and characterized a novel, purely spillover-mediated current from immature relay neurons, which strongly supports the presence of glutamate spillover between boutons of different RGCs. The results of my studies indicate that far more RGCs contribute to relay neuron firing than would be predicted by the anatomy alone. Finally, in an ongoing study, we investigated the functional role of the neuronal glutamate transporter GLT-1 at the immature retinogeniculate synapse. While GLT-1 has been found in both neurons and glia, excitatory currents at the retinogeniculate synapse were largely unaffected in mice lacking neuronal GLT-1, suggesting non-neuronal glutamate transporters are responsible for the majority of glutamate removal from the developing synapse. Taken together, these results provide insight into the synaptic environment of the developing retinogeniculate synapse and identify a number of mechanisms that shape excitatory transmission during this period of synaptic maturation and refinement.

O desenvolvimento humano pode ser influenciado pelo ambiente. Estímulos recebidos ao longo da vida determinam seu progresso e sucesso. Estímulos positivos levam ao desenvolvimento de habilidades, melhorando funções cognitivas e da memória, enquanto estímulos negativos podem predispor a patologias como o estresse. Eventos estressantes durante a infância aumentam a predisposição para o desenvolvimento de transtornos psiquiátricos ao longo da vida. A separação materna, modelo animal de estresse pós-natal, promove diversas alterações comportamentais e encefálicas. Animais submetidos à separação materna apresentam comportamentos que mimetizam doenças psiquiátricas humanas. Por outro lado, diversos trabalhos sugerem que o enriquecimento ambiental pode ter efeito benéfico na reversão ou atenuação de modificações comportamentais e encefálicas promovidas por modelos animais de depressão, esquizofrenia, ansiedade e hiperatividade. Esses aspectos motivaram-nos a estudar se as alterações causadas por estresse podem ser revertidas ou atenuadas pelo enriquecimento do ambiente. Há evidências que sugerem um importante envolvimento de células gliais e de transportadores de glutamato presentes nessas células em modelos animais de transtornos psiquiátricos. Sendo assim, investigamos a expressão de mRNA e proteínas de dois transportadores de glutamato gliais e um neuronal, do receptor de glutamato AMPA, de marcadores gliais GFAP, S100?, glutamina sintase (GS) e do marcador de neurônios maduros NeuN na camada molecular e granular do giro denteado do hipocampo de ratos de 60 dias. Observamos que a separação materna diminui a expressão das proteínas GLAST, GLT-1, GS e NeuN, reduz a expressão dos genes Gria1 (AMPA) e S100?, e aumenta a expressão da proteína EAAC1 no giro denteado. Nossos dados sugerem uma reversão das alterações causadas pela separação materna em relação ao gene Gria1/AMPA e às proteínas GLAST, GLT-1 e EAAC1 após o enriquecimento ambiental. Portanto, o enriquecimento ambiental pode reverter as modificações causadas pela separação materna nas vias glutamatérgicas. Esses efeitos benéficos podem ser investigados para auxiliar no tratamento de transtornos psiquiátricos relacionados à separação materna. / Human development can be influenced by the environment. Stimuli received throughout life determine its progress and success. Positive stimuli lead to development of skills, improving cognitive and memory functions, while negative stimuli may predispose to pathologies such as stress. Stressful events during childhood increase the predisposition to psychiatric disorders throughout life. Maternal separation, an animal model of postnatal stress, promotes several behavioral and encephalic changes. Animals submitted to maternal separation stage behaviors associated with psychiatric diseases in humans. On the other hand, some researches have suggested that environmental enrichment may have some beneficial effects on the reversal or attenuation of behavioral and encephalic modifications promoted by animal models of depression, schizophrenia, anxiety and hyperactivity, which motivates us to study if these changes, stirred by this kind of stress, can be reversed or mitigated by environmental enrichment. There are evidences suggesting the involvement of glial cells and glutamate transporters existent in these cells in psychiatric disorders and animal models of these disorders. Therefore, we investigated mRNA and protein expression of two glial and one neuronal glutamate transporters, AMPA glutamate receptor, glial markers GFAP, S100?, glutamine synthase (GS), and the NeuN neuronal marker in the molecular and granular layer of the hippocampal gyrus in sixty-days-old rats. We observed that maternal separation decreases expression of GLAST, GLT-1, GS and NeuN proteins, reduces Gria1 (AMPA) and S100? gene expression, and increases EAAC1 protein expression in the dentate gyrus. After environmental enrichment, our data suggests a reversal of the maternal separation changes in the Gria1/AMPA gene and the GLAST, GLT-1 and EAAC1 proteins. Therefore, environmental enrichment may reverse the maternal separation changes in the glutamatergic pathways. These beneficial effects may be investigated to aid in the treatment of psychiatric disorders related to maternal separation.

L'homéostasie glutamatergique dans les fentes synaptiques régule la neurotransmission et préserve de l'excitotoxicité. Cela est particulièrement important dans l'oreille interne où il y a une libération soutenue de neurotransmetteur. Pour la plupart des cellules ciliées cochléaires et vestibulaires, la clairance du glutamate est assurée par les transporteurs du glutamate EAAT1 (GLAST) exprimés par les cellules de soutien. Un tel mécanisme n'est pas possible pour les cellules ciliées vestibulaires de type I car leur terminaison synaptique en calice empêche tout accès à la fente synaptique. Nous avons donc postulé qu'un ou plusieurs transporteurs du glutamate devaient être présents au niveau des cellules ciliées de type I ou du calice ou des deux.Grâce à des enregistrements électrophysiologiques, nous avons démontré qu'un courant anionique induit par le glutamate et bloqué par le DL-TBOA est présent dans les cellules ciliées de type I. Les techniques d'hybridation in situ et d'immunohistochimie ont révélé la présence d'EAAT4 et EAAT5. Ces deux transporteurs du glutamate, qui pourraient êtres à l'origine des courants enregistrés, sont exprimés par les cellules ciliées de type I et de type II. De plus, des expériences de RT-PCR et de microscopie électronique ont confirmé ces résultats et suggéré que ces transporteurs pourraient aussi être exprimés postsynaptiquement par le calice. Ces travaux de thèse montrent qu'EAAT4 et EAAT5, considérés respectivement comme spécifiques des tissus cérébelleux et rétiniens, ont une distribution plus large. Ces résultats posent la question des rôles potentiels de ces transporteurs dans l'homéostasie glutamatergique vestibulaire. / Glutamate homeostasis in synaptic clefts shape neurotransmission and prevent excitotoxicity. This may be particularly important in the inner ear where there is a continually high rate of neurotransmitter release. In the case of most cochlear and vestibular hair cells, clearance involves the diffusion of glutamate to supporting cells, where it is taken up by EAAT1 (GLAST), a glial glutamate transporter. A similar mechanism is unlikely to work in vestibular type I hair cells because the presence of calyx endings separates supporting cells from the synaptic zone. Based on this arrangement, we postulated that a glutamate transporter must be present in the type I hair cell, the calyx ending, or both. Using whole-cell patch-clamp recordings, we demonstrated that a glutamate-activated anion current blocked by DL-TBOA is expressed in type I hair cells. In situ hybridization and immunohistochemistry revealed that EAAT4 and EAAT5, two glutamate transporters that could support the anion current, are expressed in both type I and type II hair cells. Furthermore, RT-PCR and immunogold investigations confirmed those results and added that although preferentially expressed presynaptically, the transporters may also be present in the postsynaptic calyx membrane. Previously thought to be exclusively expressed in the cerebellum and retina respectively, this thesis work shows that EAAT4 and EAAT5 have a wider distribution. The potential role of these transporters in the glutamatergic homeostasis of the calyx synapse is then discussed.

Nos travaux ont porté sur la mise au point de synthèse de nouveaux dérivés β-substitués β-hydroxy aspartates : Inhibiteurs du transport du glutamate dans le système nerveux centrale (SNC). Ces analogues d'aspartates ont été caractérisés par différentes méthodes spectroscopiques (RMN-1H, RMN-13C et HRMS) et leur pureté énantiomérique a été confirmée par analyses HPLC chirale et des mesures de pouvoir rotatoire. Ce manuscrit est organisé en trois chapitres : la première partie présente un point bibliographique sur le système glutamatergique dans le SNC, en rappelant les différents récepteurs et transporteurs du glutamate dans ce système ainsi leurs agonistes et antagonistes spécifiques.Puis, nous avons décrit un aperçu sur les différentes synthèses de dérivés aspartates β-substitués et leurs activités inhibitrices vers les transporteurs du Glu dans le SNC.Afin d'avoir une grande diversité dans la structure les dérivés β-substitués β-hydroxy aspartates et réduire le temps de préparation et le nombre d'étapes de synthèse, nous avons développé dans la troisième partie de ce manuscrit deux stratégies originales et récentes pour préparer des dérivés -substitués -hydroxy aspartates via une aminohydroxylation asymétrique de Sharpless, qui est considérée comme l'étape clé dans cette synthèse.Enfin, Les résultats préliminaires de tests biologiques sur les dérivés β-substitués β-hydroxy aspartates protégés montrent que ces composés ne présentent aucune toxicité vers les cellules nerveuses de l'hippocampe de rat. L'étude de la cytotoxicité et l'activité inhibitrice de dérivés β-substitués β-hydroxy aspartates totalement déprotégés vis à vis du transport du glutamate dans le SNC sont actuellement en cours. / Our work focused on the development of synthesis of originals β-substituted β-hydroxy aspartates derivatives: Inhibitors of glutamate transport in the central nervous system (CNS).These analogs of aspartate have been characterized by various spectroscopic methods (1H-NMR, 13C-NMR and HRMS) and their enantiomeric purity was confirmed by chiral HPLC analysis and D measurement.This manuscript is organized into three chapters: the first part presents a bibliographical point of the glutamatergic system in CNS, recalling the different receptors and glutamate transporters in this system and their specific agonists and antagonists.Then, we described an overview of the various syntheses of β-substituted aspartates derivatives and their inhibitory activities toward glutamate transporters in CNS.In order, to have a great diversity in the structure of β-substituted β-hydroxy aspartates derivatives and reduce preparation time and the number of synthetic steps, we have developed in the third part of this manuscript two recent and original strategies for prepare β-substituted β-hydroxy aspartates derivatives via asymmetric aminohydroxylation Sharpless, who is considered the key step in this synthesis. Finally, preliminary results of biological tests on optically pure aspartates derivatives showed no toxicity to nerve cells of the rat hippocampus. The study of the inhibitory activity of these derivatives towards transport of glutamate in CNS is currently underway.

Le glutamate est le principal neurotransmetteur excitateur du système nerveux central des vertébrés, et le codage de l’information cérébrale repose en partie sur des modulations de l’amplitude et de la fréquence des transmissions synaptiques glutamatergiques. De ce fait, la résolution spatiale et temporelle de ces transmissions nécessite un contrôle fin de la présence de glutamate dans la fente synaptique. Cette durée de vie du glutamate dans les synapses dépend directement de l’action de transporteurs spécifiques exprimés à la surface des astrocytes, en particulier les transporteurs de type GLT-1, qui retirent le neurotransmetteur et permettent ainsi de « nettoyer » la fente synaptique avant la survenue d’un nouvel épisode de neurotransmission. / A classic understanding of neurotransmitter clearance at glutamatergic synapses is that, in order to ensure sufficient glutamate uptake on a fast timescale, it is necessary to have high numbers of glutamate transporters in the vicinity of release sites to compensate for their slow transport kinetics. Using a combination of single molecule imaging and electrophysiological approaches, we now challenge this view by first demonstrating that GLT-1 transporters are not static but highly mobile at the surface of astrocytes, and that their surface diffusion is dependent upon both neuronal and glial cell activities. In the vicinity of glutamate synapses, GLT-1 dynamics are strongly reduced favoring their retention within this strategic location. Remarkably, glutamate uncaging at synaptic sites instantaneously increases GLT-1 diffusion, displacing the glutamate-bound transporter away from this compartment. Functionally, impairment of the transporter lateral diffusion through an antibody-based surface cross linking, both in vitro and in vivo, significantly slows the kinetics of excitatory postsynaptic currents. Taken together, these data reveal the unexpected and major role of the astrocytic surface GLT-1 fast dynamics in shaping glutamatergic synaptic transmission.Keywords:

Astrocytes are emerging as important regulators of neural circuit function and behavior in the healthy and diseased nervous system. In a screen for astrocyte molecules that modulate neuronal hyperexcitability we identified multiple components of focal adhesion complexes (FAs) as potent suppressors of genetically- or pharmacologically-induced seizure-like activity. Depletion of astrocytic Tensin, b-integrin, Talin, Focal adhesion kinase (FAK), or matrix metalloproteinase 1 (Mmp1), which degrades extracellular matrix to activate b-integrin receptors, resulted in enhanced recovery from, or resistance to seizure activity. Reciprocally, promoting FA signaling by overexpression of Mmp1 in astrocytes led to enhanced-seizure severity. Blockade of FA signaling in astrocytes led to reduced-astrocytic coverage of the synaptic neuropil and reduced expression of the excitatory amino acid transporter EAAT1. However, upon seizure induction, depletion of FA signaling components resulted in enhanced astrocyte coverage of the synaptic neuropil and a ~2-fold increase in EAAT1 levels compared to controls. Our data indicate that FAs promote astrocyte coverage in neuropil and EAAT1 expression under normal physiological conditions, but in the context of hyperexcitability, FAs negatively regulate the extent of astrocytic processes within neuropil and EAAT1 expression, thereby inhibiting a more rapid recovery from conditions of excessive neuronal activity.

La caractéristique neuropathologique majeure de la maladie de Parkinson (MP) est la perte progressive des neurones dopaminergiques (DA) de la substance noire (SN). Nous avons examiné si un dysfonctionnement aigu des EAATs pourrait contribuer au cercle vicieux entretenant la progression des pertes DA. Les effets du PDC, un inhibiteur substrat des EAATs, ont été analysés chez le rat. L'analyse cinétique (4-120 jours) des effets d'une seule injection intranigrale de PDC montre une perte progressive spécifique des neurones DA, avec une évolution unilatérale vers bilatérale et caudo-rostrale. Le processus dégénératif associe déplétion en glutathion et augmentation de l'activité de la γ-glutamyltranspeptidase, stress oxydatif, processus excitotoxiques, autophagie et réactivités gliales. L'antioxydant N-acétylcystéine et les antagonistes des récepteurs NMDA ifenprodil et mémantine exercent un effet neuroprotecteur. Des effets compensatoires transitoires au niveau de marqueurs de la fonction DA dans la SN et le striatum accompagnent la perte cellulaire et des dystrophies axonales. Des troubles moteurs apparaissent de façon tardive lorsque la perte neuronale ipsilatérale avoisine les 50%. Ces résultats montrent un lien fonctionnel entre dysfonctionnement des EAATs et plusieurs mécanismes pathogéniques ainsi que des caractéristiques neuropathologiques majeures de la MP, et fournissent le premier modèle progressif de la maladie induit de façon aiguë. / Parkinson's disease (PD) is characterized by the progressive degeneration of substantia nigra (SN) dopaminergic neurons. Central players in PD pathogenesis, including mitochondrial dysfunction and oxidative stress, might affect the function of excitatory amino acid transporters (EAATs). Here, we investigated whether acute EAATs dysfunction might in turn contribute to the vicious cycles sustaining the progression of dopamine neuron degeneration. PDC application on nigral slices triggered sustained glutamate-mediated excitation selectively in dopamine neurons. In vivo time-course study (4-120 days) revealed that a single intranigral PDC injection triggers progressive degeneration of exclusively dopamine neurons with unilateral to bilateral and caudorostral evolution. This degenerative process associates GSH depletion and specific increase in γ-glutamyltranspeptidase activity, oxidative stress, excitotoxicity, autophagy and glial reaction. The anti-oxidant N-acetylcysteine and the NMDA receptor antagonists ifenprodil and memantine provided significant neuroprotection Transient compensatory changes in dopamine function markers in SN and striatum accompanied cell loss and axonal dystrophy. Motor abnormalities (hypolocomotion and forelimb akinesia) showed late onset, when ipsilateral neuronal loss exceeded 50%. These findings outline a functional link between EAATs dysfunction and several PD pathogenic mechanisms and pathological hallmarks, and provide the first acutely-triggered rodent model of progressive parkinsonism.

L’excitotoxicité est un mécanisme physiopathologique majeur impliqué dans la pathogenèse de la déficience en thiamine (DT). Dans les régions cérébrales vulnérables à la DT, on observe une mort cellulaire induite par excitotoxicité dont l’origine semble être la conséquence d’une perturbation du métabolisme énergétique mitochondrial, d’une dépolarisation membranaire soutenue et d’une diminution de l’absorption du glutamate par les astrocytes suite à la diminution de l’expression des transporteurs EAAT1 et EAAT2. Il est clairement établi que le glutamate joue un rôle central dans l’excitotoxicité lors de la DT. Ainsi, la mise en évidence des mécanismes impliqués dans la diminution de l’expression des transporteurs du glutamate est essentielle à la compréhension de la physiopathologie de la DT. L’objectif de cette thèse consiste en l’étude de la régulation des transporteurs astrocytaires du glutamate et la mise au point de stratégies thérapeutiques ciblant la pathogenèse de l’excitotoxicité lors de l’encéphalopathie consécutive à la DT. Les principaux résultats de cette thèse démontrent des perturbations des transporteurs du glutamate à la fois dans des modèles animaux de DT et dans des astrocytes en culture soumis à une DT. La DT se caractérise par la perte du variant d’épissage GLT-1b codant pour un transporteur du glutamate dans le thalamus et le colliculus inférieur, les régions cérébrales affectées lors d’une DT, en l’absence de modification des niveaux d’ARNm. Ces résultats suggèrent une régulation post-transcriptionnelle de l’expression des transporteurs du glutamate en condition de DT. Les études basées sur l’utilisation d’inhibiteurs spécifiques des facteurs de transcription NFkB et de l’enzyme nucléaire poly(ADP)ribose polymérase-1 (PARP-1) démontrent que la régulation de l’expression du transporteur GLT-1 est sous le contrôle de voies de signalisation NFkB dépendantes de PARP-1. Cette étude démontre une augmentation de l’activation de PARP-1 et de NFkB dans les régions vulnérables chez le rat soumis à une DT et en culture d’astrocytes DT. L’inhibition pharmacologique du facteur de transcription NFkB par le PDTC induit une augmentation des niveaux d’expression de GLT-1, tandis que l’inhibition de PARP-1 par le DPQ conduit à l’inhibition de l’hyperactivation de NFkB observée lors de DT. L’ensemble de ces résultats met en évidence un nouveau mécanisme de régulation des transporteurs du glutamate par l’activation de PARP-1. L’accumulation de lactate est une caractéristique de la DT. Un traitement avec le milieu de culture d’astrocytes en condition de DT sur des cultures d’astrocytes naïfs induit une diminution de l’expression de GLT-1 ainsi qu’une inhibition de la capacité d’absorption du glutamate par les astrocytes naïfs. En revanche, l’administration de lactate exogène ne modifie pas le niveau d’expression protéique de GLT-1. Ainsi, des facteurs solubles autres que le lactate sont sécrétés par des astrocytes en condition de perturbation métabolique et peuvent potentiellement réguler l’activité des transporteurs du glutamate et contribuer à la pathogenèse du syncytium astroglial. En outre, la ceftriaxone, un antibiotique de la famille des β-lactamines, augmente de façon différentielle l’expression du variant-d’épissage GLT-1 dans le colliculus inférieur chez le rat DT et en culture d’astrocytes DT. Ces résultats suggèrent que la ceftriaxone peut constituer une avenue thérapeutique dans la régulation de l’activité des transporteurs du glutamate lors de DT. Pour conclure, la mort cellulaire d’origine excitotoxique lors de DT survient en conséquence d’une dysfonction mitochondriale associée à une perturbation du métabolisme énergétique cérébral. La modification de l’expression des transporteurs du gluatamate est sous le contrôle des voies de signalisation NFkB dépendantes du facteur PARP-1. De plus, l’inhibition métabolique et l’augmentation des sécrétions de lactate observées lors de DT peuvent également constituer un autre mécanisme physiopathologique expliquant la diminution d’expression des transporteurs de glutamate. Enfin, la ceftriaxone pourrait représenter une stratégie thérapeutique potentielle dans le traitement de la régulation de l’expression des transporteurs du glutamate et de la perte neuronale associés à l’excitotoxicité observée lors de DT. / Excitotoxicity has been implicated as a major pathophysiological mechanism in the pathogenesis of thiamine deficiency (TD). Excitotoxic-mediated cell death is localized in areas of focal vulnerability in TD and may occur as a consequence of impairment in mitochondrial energy metabolism, sustained cell membrane depolarization and decreased uptake of glutamate by astrocytes due to the loss of excitatory amino acid transporters, (EAAT1 and EAAT2). Over the years, a number of studies have identified glutamate as being a major contributor to excitotoxicity in the pathophysiology of TD. Thus, downregulation of astrocytic glutamate transporters resulting in excitotoxicity is a key feature of TD and understanding the regulation of these transporters is essential to understanding the pathophysiology of the disorder. The objective of the present thesis project was to examine the underlying basis of astrocytic glutamate transporter regulation during TD encephalopathy. Major findings of the studies presented in this thesis project provide evidence for glutamate transporter abnormalities in TD animal models and astrocyte cultures exposed to TD. TD results in the loss of the glutamate transporter splice variant-1b (GLT-1b) in vulnerable areas of brain, i.e. thalamus and inferior colliculus, with no significant alteration in the mRNA levels of the transporters, suggesting that glutamate transporter regulation under conditions of TD is a posttranscriptional event. Studies using a specific inhibitor of the transcription factor, Nuclear factor-kappa B (NF-κB) and a nuclear enzyme poly (ADP)ribose polymerase-1 (PARP-1) provided evidence for the regulation of GLT-1 by PARP-1 dependent NF-κB signalling pathways. The major findings of this study suggested an increase in the activation of PARP-1 and NF-κB molecule in the vulnerable areas of TD rat brain and TD astrocyte cultures. Pharmacological inhibition of NF-κB showed an increase in the levels of GLT-1, while inhibition of PARP-1 using a specific PARP-1 inhibitor, DPQ inhibited the increased activation of NF-κB that was observed during TD. Overall results of this finding provided evidence for a mechanism involving PARP-1 activation in the regulation of glutamate transporters. Given the increased lactate accumulation as a classical feature of TD, we studied the effect of soluble factors produced by astrocytes on glutamate transporter function. Treatment of naïve astrocyte cultures with TD conditioned media resulted in decreased levels of GLT-1 and inhibition of glutamate uptake capacity concomitant with a loss of mitochondrial membrane potential. Administration of exogenous lactic acid produced a similar reduction in glutamate uptake to that resulting from conditioned media. However, lactic acid treatment did not result in a change in GLT-1 protein levels. In addition, the pro-inflammatory cytokine TNF-α was shown to be increased in astrocytes treated with TD along with elevated levels of the phospho-IκB fragment, indicative of increased activation of NFκB. Inhibition of NFκB led to an amelioration of the decrease in GLT-1 that occurs in TD, along with recovery of glutamate uptake. Thus, soluble factors released from astrocytes under conditions of metabolic impairment such as lactate and TNF-α impairment appear to exert a regulatory influence on glutamate transporter function. Ceftriaxone, a β-lactam antibiotic, has the ability to differentially stimulate GLT-1b (splice-variant) expression in the inferior colliculus in TD rats and under in vitro conditions with TD astrocyte cultures. Thus, ceftriaxone may be a potential therapeutic strategy in the regulation of glutamate transporter function during TD. In summary, excitotoxic cell death in TD occurs as a consequence of mitochondrial dysfunction associated with cerebral energy impairment and abnormal glutamate transporter status. A major underlying mechanism for glutamate transporter abnormalities is mediated by PARP-1 dependent NF-κB signaling pathways. In addition, metabolic inhibition with substantial production of lactate and TNF-α may be perhaps another mechanism responsible for glutamate transporter downregulation in TD.